Cairo – Mubasher: Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) reported a 111% year-on-year (YoY) increase in its net profits to EGP 43.47 million during the first half (H1) of 2020, compared to EGP 20.6 million.
In the meantime, Rameda’s revenues grew to EGP 437.46 million in the January-June period from EGP 384.3 million in the year-ago period, according to a bourse disclosure on Sunday.
During the first quarter (Q1) of 2020, the company’s net profits surged to EGP 23.76 million from EGP 8.33 million in the same period in 2019.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2020 Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
